Microbix Biosystems Inc. — Investor Relations & Filings
Microbix Biosystems Inc. develops and commercializes proprietary biological and technological solutions for human health, specializing in infectious disease diagnostics. The company is a commercial-scale producer of infectious disease antigens, which are utilized as key ingredients in manufacturing diagnostic tests and for vaccine research and development. Microbix also provides a comprehensive portfolio of external quality control materials (EQC), marketed as Quality Assessment Products (QAPs™). These whole-workflow, multi-analyte controls, available in liquid and swab formulations for IVD and Research Use Only (RUO) applications, support clinical laboratory proficiency testing and assay development across various infectious disease panels, including respiratory, STI, HPV, and gastrointestinal pathogens. The company is ISO 9001 and 13485 accredited, serving the global diagnostics industry.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2023-10-27 | English | |
| News release - English.pdf | 2023-09-29 | English | |
| News release - English.pdf | 2023-09-27 | English | |
| News release - English.pdf | 2023-08-10 | English | |
| 52-109F2 - Certification of interim filings - CFO (E).pdf | 2023-08-10 | English | |
| 52-109F2 - Certification of interim filings - CEO (E).pdf | 2023-08-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 29369097 | News release - English.pdf | 2023-10-27 | English | ||
| 29291159 | News release - English.pdf | 2023-09-29 | English | ||
| 29262474 | News release - English.pdf | 2023-09-27 | English | ||
| 13688114 | News release - English.pdf | 2023-08-10 | English | ||
| 13688116 | 52-109F2 - Certification of interim filings - CFO (E).pdf | 2023-08-10 | English | ||
| 13688115 | 52-109F2 - Certification of interim filings - CEO (E).pdf | 2023-08-10 | English | ||
| 13688117 | Interim MD&A - English.pdf | 2023-08-10 | English | ||
| 13688119 | Interim financial statements/report – English.pdf | 2023-08-10 | English | ||
| 13677002 | News release - English.pdf | 2023-06-20 | English | ||
| 28654373 | News release - English.pdf | 2023-06-13 | English | ||
| 13670479 | Material change report - English.pdf | 2023-05-19 | English | ||
| 13670598 | News release - English.pdf | 2023-05-18 | English | ||
| 27997481 | News release - English.pdf | 2023-04-20 | English | ||
| 13658791 | News release - English.pdf | 2023-03-30 | English | ||
| 13653473 | News release - English.pdf | 2023-03-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Microbix Biosystems Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/43412/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=43412 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=43412 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=43412 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 43412}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Microbix Biosystems Inc. (id: 43412)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.